Consensus Document on the Clinical Management of Alopecia Areata: Recommendations from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venerology

Treatment of patients with alopecia areata (AA) has changed dramatically in recent years thanks to the development of JAK inhibitors, approved and funded in Spain for patients with extensive AA after failed treatment with systemic corticosteroids. However, the best treatment for different stages of AA remains a challenge, given the wide variety of available therapeutic options. This consensus document on the management of AA follows a Delphi method, in which 23 dermatologists from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venereology have participated. After two rounds of voting, 101 of the 125 proposed items (81%) were agreed upon, structured in 5 groups of recommendations: generalities, localized AA, moderate AA, extensive AA, and special situations. The objective of this national consensus is to support health professionals in the management of AA, based on expert consensus and available scientific evidence.